IJCRR - 7(20), October, 2015
HEALTH EDUCATION REGARDING HUMAN PAPILLOMA VIRUS (HPV VACCINE) FOR PRIMARY PREVENTION OF CERVICAL CANCER FOR PARENTS OF ADOLESCENT GIRLS
Author: Paapa Dasari, Haritha Sagili, Subitha Lakshminarayan
Objective: To assess the existing knowledge regarding causation and prevention of carcinoma cervix and to increase their awareness though a health education program addressing prevention especially by HPV vaccination among teachers and parents of school children.
Material and Methods: This was a cross sectional interventional study conducted in St. Joseph’s of Cluny School, in Puducherry. Health education regarding carcinoma cervix and its prevention was given by an illustrated lecture using powerpoint presentation and Question answer sessions. Pretest and post test questionnaire in Tamil (Local Language) and English was used. Study population was 325 mothers including school teachers. Statistical Analysis: SPSS 16 was used. All categorical variables were presented as percentages and the pre-test and post test questionnaire were compared by using Chi square test.
Results: Knowledge of causation by HPV virus improved from 50% to 98% on post test (p<0.001). There was a significant improvement (80%) regarding dosage, side effects of the vaccine and 75% improvement regarding age of administration of vaccine. There was a significant improvement in knowledge regarding efficacy of the vaccine, place of availability and cost of HPV vaccine. Acceptability if the vaccine is provided through the schools was about 92% after the health education programme.
Conclusion: Though 50% were aware about the disease and its causation the knowledge regarding its prevention by HPV vaccination and its availability was poor at baseline. After the health education programme there was a statistically significant improvement in all aspects.
Keywords: Carcinoma Cervix, Primary prevention, HPV Vaccine, Health education, Parents of adolescent girls
Paapa Dasari, Haritha Sagili, Subitha Lakshminarayan. HEALTH EDUCATION REGARDING HUMAN PAPILLOMA VIRUS (HPV VACCINE) FOR PRIMARY PREVENTION OF CERVICAL CANCER FOR PARENTS OF ADOLESCENT GIRLS International Journal of Current Research and Review. 7(20), October, 30-36
1. Human Papilloma Virus and related cancers, India. WHO/ICO ,3 red edidtion. Summary report Update June 22,2010.
2. Morbidity Mortality weekly report. Advisory committee on Immunization Practices (ACIP) recommended inmmunisation schedule for persons aged 0 through 18 years and adults aged 19 years and older. United States.2013.www,cdc.gov/mmwr/ preview/mmwrhtml/mm63e0128a1.htm.
3. Food and Drug Administration. Product approval-prescribing information [package insert]. Gardasil [human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant], Merck and Co, Inc: Food and Drug Administration 2009. Available at http://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm094042.htm. Accessed May 25, 2010.
4. Barry D, Increasing knowledge about HPV and HPV Vaccine amongest adolescents and adults through a school based setting:A Capstone Project.2013. http://scholarworks.umass.edu/nursing_dnp_capstone/31
5. Pandey D. Vanya V, Bhagat S, Binu VS, Shetty J. Awareness and attitude towards Human papilloma Virus (HPV) vaccine among medical students in a Premier Medical School in India. PLoS ONE 7(7): e40619. doi:10.1371/journal.pone.0040619
6. Allen JD, Othus MKD, Shelton RC, Norman N, Tom L, del Carmen MG.Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev; 2010; 19(9) : 2187–98.
7. Bair, R.M., Mays, R.M., Sturm, L.A., and Zimet, G.D. Acceptability of the human papillomavirus vaccine among Latina mothers. Journal of Pediatric and AdolescentGynecology, 2008 ;21(6): 329-334. doi:10.1016/j.jpag.2008.02.007
8. Diwaker H. Knowledge and awareness about health seeking behaviour and acceptability of cervical cancer vaccine in Urban women in comparision with school students. J South Asian Feder Obstet Gynae. 2012;4 :47-53.
9. Do kyung Young and Wong Yi Ker.Awareness and accepatability of human papilloma virus vaccine: an application of the instrumental variables bivariate prohibit model.BMC Public health 2012;12:31
10. Bernard, D.M., Cooper, S.C., McCaffery, K.J., Scott, C.M., Skinner S.R. The domino effect: Adolescent girls’ response to human papillomavirus vaccination. Medical Journal of Australia 2011;194(6):297-300. Retrieved from https://www.mja.com.au/ journal/2011/194.
11. Kennedy, A., Sapsis, K., Stokley, S., Curtis, C.R., and Gust, D. Parental attitudes toward human papillomavirus vaccination: Evaluations of an educational intervention, 2008. Journal of Health Communication, 2011;16, 300-313. doi:10.1080/10810 730.2010.532296
12. Kjaer SK, Sigurdsson K, Iversen OE, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) 2009;2:868–78
13. Gee J, Naleway A, Shui I, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine 2011;29;8279–84
14. Lu, B., Kimar, A., Castellsague, X., and Giuliano, A.R. . Efficacy and safety of prophylacticvaccines against cervical HPV infection and disease among women: A systematic reviewand metaanalysis. BioMed Central Infectious Disease,2014 11(13), 1-16. doi:10.1186/1471-2334-11-13
15. CDC. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010;59:630–2.
16. Sheridan A. and White, J.. Annual HPV vaccine coverage in England in2009/2010 [pdf]. .http://data.parliament.uk/DepositedPapers/Files/DEP2012-1386/PQ119371-2.pdf
17. Kadis, J.A. McRee, A., Gottlieb, S.L., Lee, M.R., Reiter, P.L., Dittus, P.J., Brewer, N.T.. Mothers’ support for voluntary provision of HPV vaccine in schools. Vaccine, 2011 29,2542-2547. doi:10.1016/j.vaccine.2011.01.067 .
18. Kelminson, K., Saville, A., Seewald, L., Stokley, S., Dickinson, L.M., Daley, M.F., Kempe, A. Parental views of school-located delivery of adolescent vaccines. Journal ofAdolescent Health, 2012; 51, 190-196. doi:10.1016/j.jadohealth.2011.11.016
19. WHO Human papillomavirus vaccines. WHO position paper. 2009;118–131
20. Pealman S et al. Knowledge and Awareness of HPV Vaccine and acceptability to vaccinate in Sub-Saharan Africa: A systematic Review. PLoS ONE 9(3): e90912. doi:10.1371/journal. pone.0090912